Protara Therapeutics’ investigational cell therapy elicited a complete response (CR) rate of 72% among 18 patients with ...

After a promising start to the year, the biotech IPO market picked up steam again late this summer, with notable offer | This ...

Donald Trump has named tech investor David Sacks to be “A.I. & Crypto Czar” as a newly created role in his administration ...

Duality Biologics has shared the first data from a phase 1/2a antibody-drug conjugate (ADC) trial, giving an early look at ...

AstraZeneca and Daiichi Sankyo have shared the data they believe can secure approval for datopotamab deruxtecan (Dato-DXd) at ...

A study from PreciseDx showed that its artificial-intelligence-guided pathology test could help predict a patient’s chances ...

Charles River Laboratories is expanding its biotech incubation offering to even earlier in the developmental pipeline.  | ...

Cleerly has claimed an additional $106 million in funding to boost the reach of its artificial intelligence programs for ...

AmplifyBio is cutting costs, closing its R&D and characterization services site in South San Francisco and laying off ...

Massachusetts-based VC shop Atlas Venture has drawn together another $450 million fund to be channeled toward innovative ...

BMS has been among the pharma giants that have bought into AI for drug discovery. In 2021, the company struck a $1.2 billion ...

Big Pharma-backed immunomodulation biotech Nuvig Therapeutics is moving its lead asset into phase 2 trials using a $161 ...